113 related articles for article (PubMed ID: 8461255)
1. Binding of RU486 and deacylcortivazol to the glucocorticoid receptor is insensitive to sulfhydryl-modifying agents.
Burollaud T; Danzé PM; Tbarka N; Formstecher P; Dautrevaux M
J Steroid Biochem Mol Biol; 1993 Mar; 44(3):217-25. PubMed ID: 8461255
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glucocorticoid receptor behaves differently when its hormone binding site is occupied by agonist (triamcinolone acetonide) or antagonist (RU486) steroid ligands.
Moudgil VK; Gunda M
Biochem Biophys Res Commun; 1991 Feb; 174(3):1239-47. PubMed ID: 1996987
[TBL] [Abstract][Full Text] [Related]
3. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
[TBL] [Abstract][Full Text] [Related]
4. Interaction of rat liver glucocorticoid receptor with a newly synthesized antisteroid ZK98299.
Zakula Z; Moudgil VK
Biochim Biophys Acta; 1991 Apr; 1092(2):188-95. PubMed ID: 2018785
[TBL] [Abstract][Full Text] [Related]
5. Activation of rat liver glucocorticoid receptor bound to the antiglucocorticoid RU38486.
Agarwal MK; Lombardo G; Eliezer N; Moudgil VK
Biochem Biophys Res Commun; 1985 Dec; 133(2):745-52. PubMed ID: 4084295
[TBL] [Abstract][Full Text] [Related]
6. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
Moudgil VK; Anter MJ; Hurd C
J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
[TBL] [Abstract][Full Text] [Related]
7. Interaction of antiglucocorticoid RU 486 with rat kidney glucocorticoid receptor.
Kalimi MY; Agarwal MK
Biochem Biophys Res Commun; 1988 May; 153(1):365-71. PubMed ID: 3377791
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of unbound rat liver glucocorticoid receptor by N-alkylmaleimides at sub-zero temperatures.
Formstecher P; Dumur V; Idziorek T; Danze PM; Sablonniere B; Dautrevaux M
Biochim Biophys Acta; 1984 Nov; 802(2):306-13. PubMed ID: 6548646
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid versus antiglucocorticoid activity: can a single functional group modification of glucocorticoid steroids always convey antiglucocorticoid activity?
Lamontagne N; Mercier L; Pons M; Thompson EB; Simons SS
Endocrinology; 1984 Jun; 114(6):2252-63. PubMed ID: 6547091
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glucocorticoid receptor transformation, subunit dissociation, and temperature-dependent inactivation by various N-substituted maleimides.
Blicq S; Danze PM; Dumur V; Formstecher P; Dautrevaux M
Biochemistry; 1988 Nov; 27(22):8436-42. PubMed ID: 3242593
[TBL] [Abstract][Full Text] [Related]
11. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
[TBL] [Abstract][Full Text] [Related]
12. Steroid binding to hepatoma tissue culture cell glucocorticoid receptors involves at least two sulfhydryl groups.
Miller NR; Simons SS
J Biol Chem; 1988 Oct; 263(29):15217-25. PubMed ID: 3170579
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the "zinc fingers" or in the N-terminal region of the DNA binding domain of the human glucocorticosteroid receptor facilitate its salt-induced transformation, but do not modify hormone binding.
Segard-Maurel I; Jibard N; Schweizer-Groyer G; Cadepond F; Baulieu EE
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):727-32. PubMed ID: 1562546
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
Schmidt TJ
Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
[TBL] [Abstract][Full Text] [Related]
15. Effects of the glucocorticoid agonist, RU28362, and the antagonist RU486 on lung phosphatidylcholine and antioxidant enzyme development in the genetically obese Zucker rat.
Langley SC; Rickett GW; Hunt A; Kelly FJ; Postle AD; York DA
Biochem Pharmacol; 1993 Feb; 45(3):543-51. PubMed ID: 8442753
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor antagonism by cyproterone acetate and RU486.
Honer C; Nam K; Fink C; Marshall P; Ksander G; Chatelain RE; Cornell W; Steele R; Schweitzer R; Schumacher C
Mol Pharmacol; 2003 May; 63(5):1012-20. PubMed ID: 12695529
[TBL] [Abstract][Full Text] [Related]
17. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.
Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH
J Endocrinol; 2001 May; 169(2):309-20. PubMed ID: 11312148
[TBL] [Abstract][Full Text] [Related]
18. Triamcinolone acetonide 21-oic acid methyl ester: a potent local antiinflammatory steroid without detectable systemic effects.
Gorsline J; Bradlow HL; Sherman MR
Endocrinology; 1985 Jan; 116(1):263-73. PubMed ID: 3855256
[TBL] [Abstract][Full Text] [Related]
19. Binding studies of RU486 in different Reuber hepatoma variants.
Chasserot-Golaz S; Beck G
Receptor; 1993; 3(1):31-7. PubMed ID: 8348081
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of R651 mutations in the putative helix 6 of rat glucocorticoid receptors.
Huang Y; Simons SS
Mol Cell Endocrinol; 1999 Dec; 158(1-2):117-30. PubMed ID: 10630412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
